Fluorescence dye for MDx 3000 assays.

Buffer used in MDx 3000 assays.

Kit containing calibrators and controls for MDx 3000.

GenVisc® 850 sodium hyaluronate (P140005) is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. GenVisc 850 is a sterile, viscoelastic, non-pyrogenic solution (pH of 6.8-7.8) of highly purified, high molecular weight hyaluronic acid (HA) with an average molecular weight of 850,000 daltons and a range of 620,000 – 1,170,000 daltons). The HA is a polymer of repeating disaccharide units of glucuronic acid and N-acetyl-glucosamine derived from a bacterial fermentation process. GenVisc 850 is supplied in a prefilled syringe containing 25 mg of HA in 2.5 mL of physiological saline solution (1% solution).

TriVisc™ 850 sodium hyaluronate (P160057) is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. TriVisc is a sterile, viscoelastic, non-pyrogenic solution (pH of 6.8-7.8) of highly purified, high molecular weight hyaluronic acid (HA) with an average molecular weight of 850,000 daltons and a range of 620,000 – 1,170,000 daltons). The HA is a polymer of repeating disaccharide units of glucuronic acid and N-acetyl-glucosamine derived from a bacterial fermentation process. TriVisc is supplied in a prefilled syringe containing 25 mg of HA in 2.5 mL of physiological saline solution (1% solution).

• 2-ply pads• Saturated with 70% isopropyl alcohol• 100 individually packed alcohol pads per box• For external use only

• 2-ply pads• Saturated with 70% isopropyl alcohol• 100 individually packed alcohol pads per box• For external use only

CLIA Waived 12 Panel Drug Test Card-(THC-COC-OPI-AMP-MET-PCP-BZ0-BAR-MTD-MDMA-OXY-PPX)

CLIA Waived 12 Panel Drug Test Card-(THC-COC-OPI-AMP-MET-PCP-BZ0-BAR-MTD-MDMA-OXY-PPX)

CLIA Waived 5 Panel Drug Test Card-(THC-COC-OPI-AMP-PCP)

CLIA Waived 5 Panel Drug Test Card-(THC-COC-OPI-AMP-PCP)

CLIA Waived 6 Panel Drug Test Card-(THC-COC-OPI-AMP-MET-PCP)

CLIA Waived 6 Panel Drug Test Card-(THC-COC-OPI-AMP-MET-PCP)

CLIA Waived Drug Test Cup-(THC-COC-OPI-AMP-PCP)

CLIA Waived Drug Test Cup-(THC-COC-OPI-AMP-PCP)

CLIA Waived Drug Test Cup-(THC-COC-OPI-AMP-MET-PCP-BZO-BAR-MTD-MDMA)

CLIA Waived Drug Test Cup-(THC-COC-MOP-AMP-MET-PCP-BZO-BAR-PPX-MTD-OXY-BUP)

CLIA Waived Drug Test Cup-(THC-COC-MOP-AMP-MET-PCP-BZO-BAR-PPX-MTD-OXY-BUP)

Thirteen Panel Clear Scan Drug Test Cup With Adulterants Drug Combo: AMP BAR BUP BZO COC MDMA MET MOR MTD OXY PCP TCA THC + AD

Twelve Panel Clear Scan Drug Test Cup Drug Combo: AMP BAR BUP BZO COC MDMA MET MOR MTD OXY PCP THC With Adulterants

Six Panel PreScreen Plus Dip Card (CLIA Waived) Drug Combo: COC AMP MET THC OPI PCP

Five Panel PreScreen Plus Cup (CLIA Waived) Drug Combo: AMP COC OPI PCP THC

Ten Panel PreScreen Plus Cup (CLIA Waived) Drug Combo: AMP BAR BZO COC MET MTD OPI OXY PCP THC With Alcohol

Ten Panel PreScreen Plus Mini Cup (CLIA Waived) Drug Combo: AMP BAR BZO COC300 MET500 MTD OPI OXY PCP THC

Twelve Panel PreScreen Mini Plus Cup (CLIA Waived) Drug Combo: AMP BAR BUP BZO COC MAMP MDMA OPI300 MTD OXY PCP THC

Twelve Panel PreScreen Plus Cup (CLIA Waived) Drug Combo: AMP BAR BZO COC MDMA MET MOP MTD OXY PCP TCA THC

Twelve Panel PreScreen Plus Cup With Adulterants (CLIA Waived) Drug Combo: AMP BAR BZO COC MDMA MET MOP MTD OXY PCP TCA THC + AD

Accessory tips for PreveLeak™ Surgical Sealant

PreveLeak™ Surgical Sealant (PreveLeak™) is a sealant developed to seal surface holes formed during surgical repair of the circulatory system and to reinforce sutured anastomoses. When applied, PreveLeak™ creates an elastic biocompatible gel that seals suture holes or gaps formed between synthetic grafts or patches and native vessel anastomosis. PreveLeak™ adheres to the native tissues as well as synthetic materials, including PTFE and Dacron grafts, and facilitates sealing along anastomotic closure lines. After application, PreveLeak™ is a natural golden color and stays soft and flexible. Animal studies showed the majority of PreveLeak™ is largely resorbed by 12 months. PreveLeak™ is provided in a double-barreled syringe assembly containing equal volumes of purified bovine serum albumin (BSA) and polyaldehyde. PreveLeak™ is supplied in a double pouch, with two delivery tips and terminally sterilized. PreveLeak™ is ready to use once the pouch is opened, the syringe cap removed, the delivery tip is attached and the tip is primed. When the plunger is depressed, the two components are thoroughly mixed as they pass through the delivery tip. After applications, the sealant is allowed to remain undisturbed for at least 60 seconds before unclamping and exposing the anastomosis to arterial pressure. PreveLeak™ is applied as a viscous liquid that gels within approximately 10-15 seconds. PreveLeak™ is terminally sterilized by e-beam irradiation and is provided in a double pouch with two delivery tips. Additional sterile delivery tips are available separately. PreveLeak™ is provided for single-use only.

PreveLeak™ Surgical Sealant (PreveLeak™) is a sealant developed to seal surface holes formed during surgical repair of the circulatory system and to reinforce sutured anastomoses. When applied, PreveLeak™ creates an elastic biocompatible gel that seals suture holes or gaps formed between synthetic grafts or patches and native vessel anastomosis. PreveLeak™ adheres to the native tissues as well as synthetic materials, including PTFE and Dacron grafts, and facilitates sealing along anastomotic closure lines. After application, PreveLeak™ is a natural golden color and stays soft and flexible. Animal studies showed the majority of PreveLeak™ is largely resorbed by 12 months. PreveLeak™ is provided in a double-barreled syringe assembly containing equal volumes of purified bovine serum albumin (BSA) and polyaldehyde. PreveLeak™ is supplied in a double pouch, with two delivery tips and terminally sterilized. PreveLeak™ is ready to use once the pouch is opened, the syringe cap removed, the delivery tip is attached and the tip is primed. When the plunger is depressed, the two components are thoroughly mixed as they pass through the delivery tip. After applications, the sealant is allowed to remain undisturbed for at least 60 seconds before unclamping and exposing the anastomosis to arterial pressure. PreveLeak™ is applied as a viscous liquid that gels within approximately 10-15 seconds. PreveLeak™ is terminally sterilized by e-beam irradiation and is provided in a double pouch with two delivery tips. Additional sterile delivery tips are available separately. PreveLeak™ is provided for single-use only.

PreveLeak™ Surgical Sealant (PreveLeak™) is a sealant developed to seal surface holes formed during surgical repair of the circulatory system and to reinforce sutured anastomoses. When applied, PreveLeak™ creates an elastic biocompatible gel that seals suture holes or gaps formed between synthetic grafts or patches and native vessel anastomosis. PreveLeak™ adheres to the native tissues as well as synthetic materials, including PTFE and Dacron grafts, and facilitates sealing along anastomotic closure lines. After application, PreveLeak™ is a natural golden color and stays soft and flexible. Animal studies showed the majority of PreveLeak™ is largely resorbed by 12 months. PreveLeak™ is provided in a double-barreled syringe assembly containing equal volumes of purified bovine serum albumin (BSA) and polyaldehyde. PreveLeak™ is supplied in a double pouch, with two delivery tips and terminally sterilized. PreveLeak™ is ready to use once the pouch is opened, the syringe cap removed, the delivery tip is attached and the tip is primed. When the plunger is depressed, the two components are thoroughly mixed as they pass through the delivery tip. After applications, the sealant is allowed to remain undisturbed for at least 60 seconds before unclamping and exposing the anastomosis to arterial pressure. PreveLeak™ is applied as a viscous liquid that gels within approximately 10-15 seconds. PreveLeak™ is terminally sterilized by e-beam irradiation and is provided in a double pouch with two delivery tips. Additional sterile delivery tips are available separately. PreveLeak™ is provided for single-use only.

PreveLeak™ Surgical Sealant (PreveLeak™) is a sealant developed to seal surface holes formed during surgical repair of the circulatory system and to reinforce sutured anastomoses. When applied, PreveLeak™ creates an elastic biocompatible gel that seals suture holes or gaps formed between synthetic grafts or patches and native vessel anastomosis. PreveLeak™ adheres to the native tissues as well as synthetic materials, including PTFE and Dacron grafts, and facilitates sealing along anastomotic closure lines. After application, PreveLeak™ is a natural golden color and stays soft and flexible. Animal studies showed the majority of PreveLeak™ is largely resorbed by 12 months. PreveLeak™ is provided in a double-barreled syringe assembly containing equal volumes of purified bovine serum albumin (BSA) and polyaldehyde. PreveLeak™ is supplied in a double pouch, with two delivery tips and terminally sterilized. PreveLeak™ is ready to use once the pouch is opened, the syringe cap removed, the delivery tip is attached and the tip is primed. When the plunger is depressed, the two components are thoroughly mixed as they pass through the delivery tip. After applications, the sealant is allowed to remain undisturbed for at least 60 seconds before unclamping and exposing the anastomosis to arterial pressure. PreveLeak™ is applied as a viscous liquid that gels within approximately 10-15 seconds. PreveLeak™ is terminally sterilized by e-beam irradiation and is provided in a double pouch with two delivery tips. Additional sterile delivery tips are available separately. PreveLeak™ is provided for single-use only.

CSI Cup - CLIA Screen In-Vitro 14 Panel Drug Test, CLICK SEAL CAP, AMP, BAR, BUP, BZO, COC, MET, MDMA, OPI, MTD, OXY, PCP, PPX, TCA, THC, 25/BX

CSI Cup - CLIA Screen In-Vitro 14 Panel + 3 AD Drug Test, CLICK SEAL CAP, AMP, BAR, BUP, BZO, COC, MET, MDMA, OPI, MTD, OXY, PCP, PPX, TCA, THC, + OX, PH, SG,

CSI Cup - CLIA Screen In-Vitro 14 Panel Drug Test, Click Seal Cap, AMP500, BAR, BUP, BZO, COC150, mAMP500, MDMA, MOP300, MTD, OXY, PCP, PPX, TCA, THC, 25/BX